MOVA M03 1.5 (Glyburide (micronized) 1.5 mg)
Pill imprint MOVA M03 1.5 has been identified as Glyburide (micronized) 1.5 mg.
Glyburide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy. Glyburide 1.5 mg is not a controlled substance under the Controlled Substance Act (CSA).
Glyburide (micronized)
- Imprint:
- MOVA M03 1.5
- Strength:
- 1.5 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Manufacturer:
- Dava Pharmaceuticals Inc.
- National Drug Code (NDC):
- 67253-0460
- Inactive Ingredients:
- silicon dioxide
lactose monohydrate
magnesium stearate
corn starch
| NDC Code | Manufacturer / Repackager |
|---|---|
| 60429-0283 | Golden State Medical Supply (repackager) |
Note: Inactive ingredients may vary.
More about glyburide
Consumer resources
- Other brands: DiaBeta, Micronase, Glynase, Glycron, More (1) »
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
